Current Concepts of the Pathogenesis and Treatment of Hypertrophic Cardiomyopathy

This publication has 12 references indexed in Scilit:

• American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
  European Heart Journal, 2003
• Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic Cardiomyopathy
  New England Journal of Medicine, 2003
• Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy
  Journal of Clinical Investigation, 2002
• Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy
  Journal of the American College of Cardiology, 2001
• Identification of a Gene Responsible for Familial Wolff–Parkinson–White Syndrome
  New England Journal of Medicine, 2001
• The Molecular Genetic Basis for Hypertrophic Cardiomyopathy
  Journal of Molecular and Cellular Cardiology, 2001
• Nonsurgical Septal Reduction for Symptomatic Hypertrophic Obstructive Cardiomyopathy: The Baylor Experience (1996?1999)
  Journal of Interventional Cardiology, 2000
• Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy–associated mutant troponin T proteins
  Journal of Clinical Investigation, 1999
• Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy
  The Lancet, 1995
• Plasma levels of atrial natriuretic peptide in hypertrophic cardiomyopathy
  The American Journal of Cardiology, 1992